| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.58B | +32.3% |
| Cost of Revenue | $1.54B | +37.8% |
| R&D Expense | $57.2M | +70.5% |
| SG&A Expense | $183.5M | +61.9% |
| Operating Income | -$560.0M | -175.5% |
| Interest Expense | $7.5M | -21.1% |
| Pre-tax Income | -$555.4M | -181.7% |
| Income Tax | $170K | +193.1% |
| Net Income | -$555.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $585.9M | -25.3% |
| Accounts Receivable | $112.4M | +41.5% |
| Inventory | $29.0M | +208.2% |
| Current Assets | $819.6M | -12.2% |
| Total Assets | $1.92B | -2.9% |
| Current Liabilities | $1.34B | +18.4% |
| Long-term Debt | $270.0M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$230.7M | -282.4% |
| Capital Expenditures | $83.6M | +448.5% |
| Investing Cash Flow | -$175.2M | -353.2% |
| Financing Cash Flow | $244.8M | -34.6% |
| Free Cash Flow | -$314.2M | -382.5% |
| -192.2% |
| EPS (Basic) | -$2.26 | -143.0% |
| EPS (Diluted) | -$2.26 | -143.0% |
| Total Liabilities |
| $1.67B |
| +34.3% |
| Stockholders' Equity | $251.9M | -65.5% |